ATE87038T1 - Molekulare klonierung und human b lymphotropischer virus klon (hblv). - Google Patents

Molekulare klonierung und human b lymphotropischer virus klon (hblv).

Info

Publication number
ATE87038T1
ATE87038T1 AT87905817T AT87905817T ATE87038T1 AT E87038 T1 ATE87038 T1 AT E87038T1 AT 87905817 T AT87905817 T AT 87905817T AT 87905817 T AT87905817 T AT 87905817T AT E87038 T1 ATE87038 T1 AT E87038T1
Authority
AT
Austria
Prior art keywords
hblv
human
clone
molecular cloning
lymphotropic virus
Prior art date
Application number
AT87905817T
Other languages
English (en)
Inventor
Steven Francis Josephs
Robert C Gallo
Flossie Yeeching Wong-Staal
Syed Zaki Salahuddin
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Application granted granted Critical
Publication of ATE87038T1 publication Critical patent/ATE87038T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16551—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87905817T 1986-08-12 1987-07-29 Molekulare klonierung und human b lymphotropischer virus klon (hblv). ATE87038T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89585786A 1986-08-12 1986-08-12
PCT/US1987/001817 WO1988001305A1 (en) 1986-08-12 1987-07-29 Molecular cloning and clones of human b lymphotropic virus (hblv)
EP87905817A EP0321489B1 (de) 1986-08-12 1987-07-29 Molekulare klonierung und human b lymphotropischer virus klon (hblv)

Publications (1)

Publication Number Publication Date
ATE87038T1 true ATE87038T1 (de) 1993-04-15

Family

ID=25405191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87905817T ATE87038T1 (de) 1986-08-12 1987-07-29 Molekulare klonierung und human b lymphotropischer virus klon (hblv).

Country Status (8)

Country Link
EP (1) EP0321489B1 (de)
JP (1) JP2555118B2 (de)
AT (1) ATE87038T1 (de)
AU (1) AU615882B2 (de)
CA (1) CA1322342C (de)
DE (1) DE3784939T2 (de)
IL (1) IL83423A0 (de)
WO (1) WO1988001305A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009814A1 (en) * 1987-06-01 1988-12-15 Baylor College Of Medicine Expression of immunologically active proteins of human b-lymphotropic virus
FR2651007B1 (fr) * 1989-08-18 1992-09-04 Pasteur Institut Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procede de diagnostic des infections a hhv6
JP2760896B2 (ja) * 1991-04-11 1998-06-04 シーダーズ―サイナイ・メディカル・センター ＨＩＶ特異的ＩｇＭの検出のための免疫検定

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
WO1984004327A1 (en) * 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III

Also Published As

Publication number Publication date
DE3784939T2 (de) 1993-07-08
JPH02500326A (ja) 1990-02-08
EP0321489A4 (en) 1991-03-13
CA1322342C (en) 1993-09-21
AU7877387A (en) 1988-03-08
WO1988001305A1 (en) 1988-02-25
JP2555118B2 (ja) 1996-11-20
IL83423A0 (en) 1988-01-31
AU615882B2 (en) 1991-10-17
EP0321489B1 (de) 1993-03-17
DE3784939D1 (de) 1993-04-22
EP0321489A1 (de) 1989-06-28

Similar Documents

Publication Publication Date Title
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
HUP0003911A2 (hu) Neoplazmák kezelése vírusokkal
FI934937A0 (fi) Sekvenser av HCV-genom foer diagnostisk och terapi
NO874750D0 (no) Bestemte dna-sekvenser avledet fra en papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
IE900854L (en) Immunogenic regions on the E7 protein of human¹papillomavirus type 16
DE69331050D1 (de) Produktion virus-resistenter pflanzen durch einführung von nicht-translatierbarer viraler plus-strang-rna
DK0549615T3 (da) Sukkermodificerede oligonukleotider der påviser og modulerer genekspression
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
DE3650175D1 (de) Synthetische antigene zum nachweis von aids.
ES2064077T3 (es) Integracion estable de adn en genomas bacterianos.
GR890100799A (el) Μεθοδος παρασκευης συνθετικης ιντερλευκινης-6.
ATE54009T1 (de) Molekulare klone des genoms von htlv-iii.
AU597698B2 (en) Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
SE9002589L (sv) Neutrofil-aktiverande peptid-2
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
DE3782867D1 (en) Human cytomegalovirus phospho-protein
JPS55154919A (en) Preparation of interferon
ATE87038T1 (de) Molekulare klonierung und human b lymphotropischer virus klon (hblv).
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
FI923020A0 (fi) Inte a inte b-sekvenser.
FI881123A (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
EP0218431A3 (en) Novel polypeptides, dnas that code for the same and method of preparing said polypeptides and dnas
EP0370710A3 (de) DNS-Sequenz, die das Gen des Ueberzugsproteins vom Kartoffelblattroli-Virus kodiert
RU2136286C1 (ru) Противовирусное средство к рнк- и днк-содержащим вирусам

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time